rs2943641 — IRS1 Near-gene C>T

Regulates insulin signaling efficiency and cellular glucose uptake

See your personal result for IRS1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Insulin Resistance Switch — How Efficiently Your Cells Respond to Insulin

Your IRS1 (Insulin Receptor Substrate 1) gene encodes the first protein activated when insulin binds to its receptor on cell surfaces. Think of it as the ignition switch for your entire insulin signaling system11 IRS1 is phosphorylated by the insulin receptor and then activates downstream pathways like PI3K/AKT that control glucose uptake, glycogen synthesis, and protein metabolism. This variant sits approximately 500 kb upstream of IRS1 and regulates how much IRS1 protein your muscle cells produce.

The Mechanism

The C allele at rs2943641 reduces IRS1 protein levels in skeletal muscle by approximately 30% and decreases insulin-stimulated phosphatidylinositol-3-OH kinase (PI3K) activity22 PI3K is the lipid kinase that IRS1 recruits after phosphorylation — it generates PIP3, which activates AKT to trigger GLUT4 translocation and glucose uptake. With less IRS1 protein available, insulin's signal gets dampened right at the source. Your pancreas compensates by secreting more insulin (hyperinsulinemia), but your muscles and liver remain relatively resistant to insulin's effects.

This creates a vicious cycle: higher insulin levels → more fat storage → more insulin resistance → even higher insulin. Breaking this cycle requires optimizing your diet to minimize insulin demand.

The Evidence

The original discovery GWAS33 original discovery GWAS
Rung et al. Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia. Nat Genet, 2009 identified rs2943641 in 14,358 European participants with an odds ratio of 1.19 for type 2 diabetes per C allele (P = 9.3 × 10⁻¹²). Functional studies confirmed the C allele's association with reduced IRS1 protein and impaired PI3K activity in human muscle biopsies.

The POUNDS LOST trial44 POUNDS LOST trial
Qi et al. IRS1 gene variation modifies insulin resistance response to weight-loss diets. Circulation, 2011 randomized 738 adults to four diets varying in macronutrient content for 2 years. At 6 months, CC carriers on the highest-carbohydrate diet (65% carbs, 20% fat) showed greater improvements in insulin resistance (HOMA-IR decreased by 0.27 vs 0.01 for CT/TT, P=0.009) and lost more weight (6.5 kg vs 4.5 kg, P=0.015). On the lowest-carbohydrate diet (35% carbs, 40% fat), the pattern reversed — non-CC carriers did better. This gene-diet interaction was significant (P<0.05) and persisted at 2 years for HOMA-IR (P=0.023).

A four-population vitamin D study55 four-population vitamin D study
Powe et al. Circulating 25-hydroxyvitamin D, IRS1 variant rs2943641, and insulin resistance. Clin Chem, 2014 in 3,065 women found a striking gene-nutrient interaction: higher vitamin D levels (25(OH)D) reduced insulin resistance only in TT homozygotes, not in C carriers. For every 10 ng/ml increase in vitamin D, TT carriers saw HOMA-IR drop by 8% (pooled β = −0.008, P=0.004). This interaction was consistent across Boston Puerto Rican, Framingham Offspring, CARDIA, and Nurse's Health Study II cohorts and was female-specific.

Lipid effects66 Lipid effects
Bacci et al. The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides. Atherosclerosis, 2011 examined 2,037 diabetic subjects and found each C allele decreased HDL cholesterol by 1 mg/dl (P=0.0045) and increased triglycerides by 6 mg/dl (P=0.018), independent of BMI.

Practical Implications

This variant creates a metabolic fork in the road. If you have the CC genotype, a higher-carbohydrate, lower-fat diet (Mediterranean or plant-based) improves insulin sensitivity more than a low-carb or ketogenic approach. The mechanism: lower dietary fat means less intramyocellular lipid accumulation, which would otherwise further impair the already-compromised insulin signaling.

For CT and TT genotypes, dietary flexibility is greater, though TT carriers uniquely benefit from optimizing vitamin D status.

Interactions

This variant interacts with dietary macronutrients in a sex-specific manner. A two-population study77 A two-population study
Qi et al. Modulation by dietary fat and carbohydrate of IRS1 association with type 2 diabetes traits. Diabetes Care, 2013 found the protective T allele reduced T2D risk only in women with low carbohydrate intake and in men with low fat intake — suggesting men and women with this variant may need different macronutrient strategies.

The rs2943641 variant is in strong linkage disequilibrium with rs7578326 (both track together) and is independent of the IRS1 coding variant rs1801278 (G972R), which is 567 kb away.

For cancer risk, the SOS cohort88 SOS cohort
Carlsson et al. The IRS1 rs2943641 variant and risk of future cancer among morbidly obese individuals. JCEM, 2013 found T allele carriers had lower cancer incidence, but only among individuals with BMI >40. This suggests the metabolic protection from lower insulin resistance translates to reduced cancer risk in the most insulin-resistant populations.

Nutrient Interactions

vitamin D altered_metabolism
dietary carbohydrate altered_metabolism
dietary fat altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

TT Insulin Sensitive Normal

Optimal insulin signaling — lower diabetes risk, vitamin D responsive

Your cells produce full levels of IRS1 protein, allowing efficient insulin signal transduction. When insulin binds its receptor, your muscle cells rapidly phosphorylate IRS1, recruit PI3K, generate PIP3, activate AKT, and translocate GLUT4 to the membrane for glucose uptake. This is the reference standard against which CC and CT carriers are compared.

The vitamin D interaction is particularly striking and was consistent across four cohorts. The mechanism is likely vitamin D receptor (VDR) modulation of insulin signaling components, but the effect is genotype-dependent — you have the optimal IRS1 background to benefit.

Your baseline HDL is 1-2 mg/dl higher and triglycerides 6-12 mg/dl lower than CC carriers, independent of diet and exercise, giving you a modest cardiovascular advantage.

CT Flexible Metabolizer Intermediate

Moderately reduced insulin signaling — flexible with macronutrient ratios

With one functional copy of the gene producing normal IRS1 levels and one producing reduced levels, your overall IRS1 protein is approximately 15% lower than TT homozygotes. This modest reduction doesn't create the same dramatic gene-diet interaction seen in CC carriers, but you still benefit from minimizing intramyocellular lipid accumulation.

Your HDL is approximately 0.5-1 mg/dl lower and triglycerides 3-6 mg/dl higher than TT carriers. This modest dyslipidemia becomes more pronounced with weight gain or sedentary lifestyle.

CC High Carb Responder Reduced

Reduced insulin signaling efficiency — optimizes on higher-carb, lower-fat diets

The mechanism behind this paradoxical diet response is intramyocellular lipid accumulation. When you have reduced IRS1 signaling capacity and eat a high-fat diet, fatty acids accumulate in muscle cells as diacylglycerols and ceramides, which further inhibit IRS1 through serine phosphorylation — a vicious cycle. A higher-carb, lower-fat diet minimizes this lipotoxicity, allowing your limited IRS1 pool to function optimally.

Your HDL cholesterol is likely 1-2 mg/dl lower and triglycerides 6-12 mg/dl higher than if you had the TT genotype, independent of weight. Monitor your lipid panel and consider a Mediterranean dietary pattern, which has been shown to improve both insulin sensitivity and cardiovascular markers in individuals with insulin resistance variants.